Clinical Trials Logo

Clinical Trial Summary

The purpose of this patient tracking program is to monitor long term safety and effectiveness of the Novilaseā„¢ device and method in real world application.


Clinical Trial Description

ABLATE is a prospective, observational multi-center tracking database which will evaluate clinical outcomes from patients undergoing Novilase for benign breast conditions (i.e. fibroadenomas, papillomas, etc). Data captured will assess the potential advantages and disadvantages of the procedure as compared with lumpectomy. Tumor characteristics, equipment used, complications, patient satisfaction and cosmesis ratings will also be tracked. ;


Study Design


Related Conditions & MeSH terms

  • Benign Breast Conditions; Breast Fibroadenomas
  • Fibroadenoma

NCT number NCT00807924
Study type Observational
Source Novian Health Inc.
Contact
Status Completed
Phase
Start date December 2008
Completion date August 8, 2018